Intravenous Artesunate for Severe Malaria in Travelers, Europe

Multicenter trials in Southeast Asia have shown better survival rates among patients with severe malaria, particularly those with high parasitemia levels, treated with intravenous (IV) artesunate than among those treated with quinine. In Europe, quinine is still the primary treatment for severe mala...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zoller, Thomas, Junghanss, Thomas, Kapaun, Annette, Gjørup, Ida, Richter, Joachim, Hugo-Persson, Mats, Mørch, Kristine, Foroutan, Behruz, Suttorp, Norbert, Yürek, Salih, Flick, Holger
Format: Artigo
Sprache:Inglês
Veröffentlicht: Centers for Disease Control and Prevention 2011
Schlagworte:
Synopsis
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321768/
https://ncbi.nlm.nih.gov/pubmed/21529383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid1705.101229
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge